510(k) K090753
K090753 is an FDA 510(k) premarket notification submitted by Theratest Laboratories, Inc. for the device "THERATEST EL-ANTI-CCP/2". The FDA issued a decision of Substantially Equivalent on Mar 5, 2010. The device falls under product code NHX (Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)), a Class II device regulated under 21 CFR 866.5775. Theratest Laboratories, Inc. has 21 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 5, 2010
- Date Received
- Mar 20, 2009
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
- Device Class
- Class II
- Regulation Number
- 866.5775
- Review Panel
- IM
- Submission Type
- 510(k)
The device is used for the detection of anti-cyclic citrullinated peptide (CCP) antibodies in human serum or plasma as an aid in the diagnosis of rheumatoid arthritis.
Need the full FDA record for Theratest Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.